Skip to main content
FinSpry Logo
FinSpry
CHRS logo
CHRS
(NASDAQ)
Coherus Oncology, Inc.
$1.43-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Coherus Oncology (CHRS) Stock Price & Financial Analysis

Coherus Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.40 - $1.45
52-Week High$2.62
52-Week Low$0.81
Open$1.42
Volume438.54K
Average Volume (3M)907.73K
Market Cap195.05M
Shares Outstanding136.40M
P/E Ratio (TTM)1.00
Price to Sales (P/S)4.16
Price to Book (P/B)2.48
EV/EBITDA-0.83
Revenue (TTM)46.88M
Net Income (TTM)195.64M
Free Cash Flow (TTM)-170.57M
EPS (TTM)$1.60
Profit Margin417.29%
Operating Margin-366.55%
Return on Equity (ROE)248.83%
Debt to Equity0.69
50-Day MA$1.50
200-Day MA$1.61
52-Week Change46.13%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Coherus Oncology

What is the current stock price for CHRS?

As of the latest trading session, CHRS stock trades at $1.43. The 52-week range is $0.81–$2.62, with a day range of $1.40–$1.45.

What is the P/E ratio for CHRS?

Coherus Oncology's trailing P/E ratio is 1.0, meaning investors pay $1.0 for every $1 of annual earnings. Coherus Oncology operates in the Healthcare sector.

Does CHRS pay dividends?

Coherus Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CHRS?

Based on 5 analysts, the consensus for CHRS is Buy.

What is the market cap of CHRS?

Coherus Oncology's market capitalization is $195.0M, classifying it as a micro-cap company. Coherus Oncology operates in the Healthcare sector within the Biotechnology industry.